French British Institute
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TIMSIT, Jean-François JT
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants with Bacterial Pneumonia (XNW4107-302, )

Completed
3
450
Europe, US, RoW
Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio
Evopoint Biosciences Inc.
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
09/24
09/24
MULTI-CAP, NCT03452826: Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia

Completed
N/A
411
Europe
Antibiotic therapy according to the result of mPCR (device), Antibiotic therapy to be adapted according to the result of mPCR (device)
Assistance Publique - Hôpitaux de Paris
Community-acquired Pneumonia
08/22
03/23
DeepCath, NCT05440396: Identifying Local Signs at the Catheter Insertion Site With Artificial Intelligence

Recruiting
N/A
1000
Europe
Photographs collection phase, Photographs reviewing phase by medical experts, Development/Validation of artificial intelligence algorithm
Outcome Rea, Assistance Publique - Hôpitaux de Paris, National Network Surveillance and Prevention of Infections Associated with Invasive Devices SPIADI, University Hospital, Clermont-Ferrand, University Hospital, Grenoble, UNICANCER, Université Grenoble-Alpes
Catheter Infection
12/23
12/23
ADDICT, NCT06738771: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Recruiting
N/A
600
Europe, RoW
Centre Hospitalier Régional d'Orléans
Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics
01/27
01/27
PHENOMENON, NCT06916481: Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures

Not yet recruiting
N/A
300
Europe
Assistance Publique - Hôpitaux de Paris
Community Acquired or Acquiring Hospital Acquired Pneumonia
09/27
09/28
PRECOM, NCT05321459: Predictive Outcome in Comatose Patients

Recruiting
N/A
100
Europe
Neurological prognosis
Assistance Publique - Hôpitaux de Paris, Ecole Normale Supérieure de Paris
Coma, Heart Arrest, Cardiopulmonary Resuscitation
03/26
05/26
Garrouste-Orgeas, Maité
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TIMSIT, Jean-François JT
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants with Bacterial Pneumonia (XNW4107-302, )

Completed
3
450
Europe, US, RoW
Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio
Evopoint Biosciences Inc.
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
09/24
09/24
MULTI-CAP, NCT03452826: Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia

Completed
N/A
411
Europe
Antibiotic therapy according to the result of mPCR (device), Antibiotic therapy to be adapted according to the result of mPCR (device)
Assistance Publique - Hôpitaux de Paris
Community-acquired Pneumonia
08/22
03/23
DeepCath, NCT05440396: Identifying Local Signs at the Catheter Insertion Site With Artificial Intelligence

Recruiting
N/A
1000
Europe
Photographs collection phase, Photographs reviewing phase by medical experts, Development/Validation of artificial intelligence algorithm
Outcome Rea, Assistance Publique - Hôpitaux de Paris, National Network Surveillance and Prevention of Infections Associated with Invasive Devices SPIADI, University Hospital, Clermont-Ferrand, University Hospital, Grenoble, UNICANCER, Université Grenoble-Alpes
Catheter Infection
12/23
12/23
ADDICT, NCT06738771: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Recruiting
N/A
600
Europe, RoW
Centre Hospitalier Régional d'Orléans
Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics
01/27
01/27
PHENOMENON, NCT06916481: Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures

Not yet recruiting
N/A
300
Europe
Assistance Publique - Hôpitaux de Paris
Community Acquired or Acquiring Hospital Acquired Pneumonia
09/27
09/28
PRECOM, NCT05321459: Predictive Outcome in Comatose Patients

Recruiting
N/A
100
Europe
Neurological prognosis
Assistance Publique - Hôpitaux de Paris, Ecole Normale Supérieure de Paris
Coma, Heart Arrest, Cardiopulmonary Resuscitation
03/26
05/26
Garrouste-Orgeas, Maité
No trials found

Download Options